The Immunotherapy of Cancer Conference is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of.
The CAR T-cell therapy lisocabtagene maraleucel produced rapid and durable responses in heavily pretreated patients with relapsed/refractory mantle cell lymphoma.
/PRNewswire/ Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),.
Diversity Panel Discusses Asian Experience in Cancer Research Hosted by Society for Immunotherapy of Cancer and Others
Share Article
The Society for Immunotherapy of Cancer (SITC), in collaboration with the Chinese American Hematologist and Oncologist Network (CAHON) and the Indo-American Cancer Association (IACA), is pleased to release an important diversity panel discussion of society leaders sharing their experience as Asians working in the cancer research field.
Barriers to Asians and Pacific Islanders in Science and Medicine Diversity Panel Logo
This diversity panel features a timely and intimate discussion of the interactions my fellow Asian colleagues have experienced in the laboratory and the clinic, stories that are unfortunately all too common,” said SITC President Patrick Hwu, MD.